← Evidence map

ReviewFuture oncology (London, England)2015

Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis.

Cecilia Arana Yi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

34 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 25757677